Early NEC Detection via BOS: Pilot Data Signals Shift in NICU Protocols but Demands Rigorous Validation

The Lurie Children's first-in-human pilot (observational, n=96 preemies <36 weeks, no RCT) demonstrates BOS can flag NEC tissue changes in two minutes via abdominal infrared reflectance, preceding radiographic signs. This addresses a critical gap, as NEC mortality exceeds 20% once perforation occurs, yet the study lacks longitudinal outcome tracking and excludes cardiac or wall-defect cases, limiting generalizability. Prior mouse-model work from the same Northwestern group established spectral signatures of ischemia, but human translation overlooks confounding factors like feeding status or antibiotic exposure that alter gut perfusion. A 2022 multicenter cohort in JAMA Pediatrics (n=2,837) linked delayed NEC diagnosis to 3-fold higher surgery rates; BOS could interrupt this trajectory if integrated into daily rounds. Conflicts appear minimal, with engineering collaboration disclosed, yet industry ties for device scaling remain unaddressed. Overall, this observational evidence is promising for bedside screening but insufficient for practice change without powered RCTs.